We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.40
Bid: 105.00
Ask: 105.40
Change: 1.40 (1.35%)
Spread: 0.40 (0.381%)
Open: 103.40
High: 105.80
Low: 103.20
Prev. Close: 104.00
PZC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

27 Apr 2021 07:00

RNS Number : 6451W
PZ CUSSONS PLC
27 April 2021
 

Continued momentum in an exceptional year - and investing in building brands for life

 

PZ Cussons plc ("PZ Cussons" or the "Group") today issues the following trading update in respect of its third quarter, ended 27 February 2021.

 

Highlights

 

· Q3 revenue (1) growth of 4.7%, up to £145.3m

· All Regions grew revenue (1) and profit versus the prior year

· Must Win Brands revenue (1) increased 12%, fuelling overall performance

· Carex in the UK and Morning Fresh in Australia and Nigeria performed strongly, with both brands continuing to meet the evolving hygiene needs of our consumers

· Strong performance amongst our other Must Win Brands

- Sanctuary Spa delivered strong double-digit growth, thanks to increased bricks and mortar retail sales and exceptional online performance

- Original Source returned to growth in the quarter

- Cussons Baby grew in both Indonesia and Nigeria, continuing the year to date trend

· Continued investment behind our brands, strategic capabilities and operations, with Media & Consumer spend in the quarter up approximately 30% on the prior year

· Balance Sheet remains robust. Net Debt, of £35m, is down from £116m a year ago

 

Quarter 3

£m

Growth vs. Q3 FY20

(reported)

Growth vs. Q3 FY20

(constant currency)

Europe & Americas

44.4

8.1%

8.7%

Asia Pacific

47.2

1.4%

2.6%

Africa

52.7

(7.0)%

3.2%

Central

1.0

16.9%

18.8%

Group

145.3

0.1%

4.7%

 

(1) Revenue growth is quoted on a constant currency basis, unless otherwise stated

 

Outlook

Despite continued market volatility, we remain on track to perform in line with the current range of market expectations for full year FY21.

 

Jonathan Myers, Chief Executive Officer, commented "Our third quarter results maintained the renewed momentum of our business despite the quarter ending with the anniversary of the start of the global COVID-19 pandemic. The encouraging growth was broad-based, with all Regions delivering top and bottom-line growth, enabling the Group to deliver operating margins ahead of Q3 last year, while continuing to increase investment behind our Must Win Brands and new strategic capabilities. In the final quarter of this current financial year, as some of our brands come up against strong levels of demand in the base period, we intend to continue increasing investment behind building our brands and capabilities, to maintain momentum as we move to more normal comparatives.

 

Looking ahead, we will continue to proactively navigate the volatility of the pandemic, the competitive landscape and commodity cost headwinds, but at the same time remain focused on executing the initial phase of our new strategy - Building Brands for Life, Today and for Future Generations.

 

We continue to take the appropriate steps to safeguard the health and wellbeing of our employees during the pandemic, and to ensure our supply chain remains resilient and fully operational. I'd like to thank our employees in all our markets for their continued dedication to PZ Cussons and our consumers."

 

FY21 reporting timetable

In light of the impact of COVID-19 on reporting and audit procedures, and further to the Financial Conduct Authority's (FCA) policy statement issued on 27 January 2021, the Group confirms it intends to report preliminary results for the year to 31 May, in September. The Group also intends to issue a pre-close trading statement, as soon after the year end as is practical.

 

Notes to Editors

Sales data is for the 13 weeks to 27 February 2021

Figures are unaudited, and not subject to review by the Group's auditors

 

Cautionary note regarding forward-looking statements

This announcement contains certain forward-looking statements relating to expected or anticipated results, performance or events. Such statements are subject to normal risks associated with the uncertainties in our business, supply chain and consumer demand along with risks associated with macro-economic, political and social factors in the markets in which we operate. Whilst we believe that the expectations reflected herein are reasonable based on the information we have as at the date of this announcement, actual outcomes may vary significantly owing to factors outside the control of the Group, such as cost of materials or demand for our products, or within our control such as our investment decisions, allocation of resources or changes to our plans or strategy. The Group expressly disclaims any obligation to revise forward-looking statements made in this or other announcements to reflect changes in our expectations or circumstances. No reliance may be placed on the forward looking statements contained within this announcement.

 

For further enquiries, please contact

 

Investors

Sarah Pollard, PZ Cussons plc - Chief Financial Officer

0161 435 1000

Media

Tim Linacre / Guy Scarborough / Bryn Woodward - Instinctif

020 7457 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUNSBRAAUSUAR
Date   Source Headline
24th Apr 20247:00 amRNSQ3 Trading and update on strategic actions
19th Apr 20248:49 amRNSDirector/PDMR Shareholding
12th Apr 202411:04 amRNSDirector/PDMR Shareholding
8th Apr 20245:29 pmRNSDirector/PDMR Shareholding
19th Mar 202410:30 amRNSDirector/PDMR Shareholding
23rd Feb 20243:47 pmRNSDirector/PDMR Shareholding
19th Feb 20243:18 pmRNSDirector/PDMR Shareholding
8th Feb 20243:40 pmRNSDirector/PDMR Shareholding
8th Feb 20243:09 pmRNSDirector/PDMR Shareholding
8th Feb 20243:07 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNS2024 Interim Results
19th Jan 202410:50 amRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSDirectorate Change
18th Dec 20233:10 pmRNSDirector/PDMR Shareholding
4th Dec 20233:03 pmRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirectorate Change
29th Nov 202312:10 pmRNSDirector/PDMR Shareholding
29th Nov 202312:08 pmRNSDirector/PDMR Shareholding
23rd Nov 20235:57 pmRNSResult of AGM
23rd Nov 20237:00 amRNSAGM Trading Statement
20th Nov 20231:58 pmRNSDirector/PDMR Shareholding
19th Oct 202310:00 amRNSDirector/PDMR Shareholding
10th Oct 202311:10 amRNSDirector/PDMR Shareholding
5th Oct 20233:44 pmRNSHolding(s) in Company
27th Sep 202310:00 amRNSPreliminary Results - Correction
26th Sep 20237:00 amRNSPZ Cussons Preliminary Results
20th Sep 202311:09 amRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSAcquisition of minority ownership of PZCN Plc
21st Aug 20232:07 pmRNSDirector/PDMR Shareholding
26th Jul 20239:22 amRNSDirector/PDMR Shareholding
19th Jul 202310:23 amRNSDirector/PDMR Shareholding
11th Jul 20232:06 pmRNSDirector/PDMR Shareholding
4th Jul 20237:00 amRNSCapital Markets Event
30th Jun 20232:18 pmRNSDirector/PDMR Shareholding
29th Jun 202311:06 amRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSTrading Statement
21st Jun 20239:59 amRNSDirector/PDMR Shareholding
16th Jun 20237:00 amRNSDirectorate Change
19th May 20239:27 amRNSDirector/PDMR Shareholding
21st Apr 20239:00 amRNSIntention to Conduct Audit Tender
19th Apr 202310:01 amRNSDirector/PDMR Shareholding
13th Apr 20233:18 pmRNSHolding(s) in Company
13th Apr 20237:00 amRNSQ3 Trading Update
12th Apr 20232:18 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSDirectorate Change
21st Mar 20239:30 amRNSDirector/PDMR Shareholding
17th Mar 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20239:31 amRNSDirector/PDMR Shareholding
8th Feb 20237:00 amRNS2023 Interim Results
19th Jan 20234:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.